Hong Luo

机构：Nanjing Agricultural University, Chongqing University, China Pharmaceutical University, Xiamen University, Chinese Academy of Sciences, Naval University of Engineering, Beijing Institute of Genomics, First Affiliated Hospital of Xiamen University, Gannan Medical University, First Affiliated Hospital of Gannan Medical University, Chongqing Cancer Hospital, Shougang (China), Shanghai Center For Bioinformation Technology, State Key Laboratory of Natural Medicine, Clemson University · ORCID：0000-0001-5643-7525

发表论文 181 篇 · 总被引 8958 次 · h-index 42

代表论文

• Database resources of the National Genomics Data Center, China National Center for Bioinformation in 2026 (2025 · Nucleic Acids Research · 被引 32)
• CmMYC2 – CmMYBML1 module orchestrates the resistance to herbivory by synchronously regulating the trichome development and constitutive terpene biosynthesis in Chrysanthemum (2024 · New Phytologist · 被引 31)
• Phase 3 AMPLITUDE trial: Niraparib (NIRA) and abiraterone acetate plus prednisone (AAP) for metastatic castration-sensitive prostate cancer (mCSPC) patients (pts) with alterations in homologous recombination repair (HRR) genes. (2025 · Journal of Clinical Oncology · 被引 21)
• A single-arm, multicenter, phase 2 clinical study of recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate (MRG002) in HER2-positive unresectable locally advanced or metastatic urothelial carcinoma (2024 · European Journal of Cancer · 被引 10)
• SugarcaneOmics: An integrative multi-omics platform for sugarcane research (2025 · Plant Communications · 被引 9)
• Machine Learning Early Detection of SARS‐CoV‐2 High‐Risk Variants (2024 · Advanced Science · 被引 8)